Deutsche Bank AG Acquires 156,524 Shares of Teleflex Incorporated (NYSE:TFX)

Deutsche Bank AG increased its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 62.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 407,129 shares of the medical technology company's stock after purchasing an additional 156,524 shares during the period. Deutsche Bank AG owned 0.88% of Teleflex worth $72,461,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in TFX. Barclays PLC raised its holdings in Teleflex by 1.6% during the third quarter. Barclays PLC now owns 89,907 shares of the medical technology company's stock worth $22,233,000 after purchasing an additional 1,426 shares in the last quarter. Franklin Resources Inc. raised its holdings in Teleflex by 64.3% during the third quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company's stock worth $2,298,000 after purchasing an additional 3,790 shares in the last quarter. Principal Financial Group Inc. raised its holdings in Teleflex by 2.7% during the third quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company's stock worth $19,887,000 after purchasing an additional 2,086 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Teleflex by 4.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company's stock valued at $588,000 after buying an additional 128 shares in the last quarter. Finally, Czech National Bank increased its holdings in shares of Teleflex by 4.9% in the fourth quarter. Czech National Bank now owns 10,070 shares of the medical technology company's stock valued at $1,792,000 after buying an additional 472 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Stock Up 2.1%

NYSE:TFX traded up $2.66 during trading hours on Friday, hitting $129.15. 542,769 shares of the stock traded hands, compared to its average volume of 638,696. The firm has a 50 day moving average price of $132.83 and a 200 day moving average price of $162.37. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a fifty-two week low of $120.06 and a fifty-two week high of $249.91. The firm has a market cap of $5.71 billion, a price-to-earnings ratio of 25.67, a PEG ratio of 1.73 and a beta of 1.17.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. During the same period in the prior year, the business posted $3.21 earnings per share. Teleflex's revenue for the quarter was down 5.0% compared to the same quarter last year. Equities research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex's dividend payout ratio (DPR) is presently 42.90%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on TFX shares. Piper Sandler reaffirmed a "neutral" rating and issued a $140.00 price target (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Royal Bank of Canada dropped their price target on Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a report on Friday, May 2nd. Citizens Jmp cut Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Morgan Stanley dropped their price target on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a report on Monday, May 5th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Teleflex presently has a consensus rating of "Hold" and a consensus price target of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.